NVDA vs. GMED
NVDA (NVIDIA Corporation) and GMED (Globus Medical, Inc.) are both stocks. NVDA operates in Semiconductors (Technology), while GMED operates in Medical Devices (Healthcare). Over the past 10 years, NVDA returned 64.62%/yr vs 12.86%/yr for GMED. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
NVDA vs. GMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVDA achieves a 7.77% return, which is significantly higher than GMED's -9.76% return. Over the past 10 years, NVDA has outperformed GMED with an annualized return of 64.62%, while GMED has yielded a comparatively lower 12.86% annualized return.
NVDA
- 1D
- 2.93%
- 1M
- 1.60%
- 6M
- 5.16%
- YTD
- 7.77%
- 1Y
- 13.01%
- 3Y*
- 62.93%
- 5Y*
- 59.52%
- 10Y*
- 64.62%
- ALL TIME*
- 36.28%
GMED
- 1D
- -1.83%
- 1M
- 3.73%
- 6M
- -13.11%
- YTD
- -9.76%
- 1Y
- 49.71%
- 3Y*
- 10.13%
- 5Y*
- -1.08%
- 10Y*
- 12.86%
- ALL TIME*
- 13.68%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $96.46M | $126.87M | $149.45M | |
| $25.46B | $26.13B | $31.85B |
NVDA vs. GMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVDA NVIDIA Corporation | 7.77% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 122.30% | 76.94% | -30.82% | 81.99% |
GMED Globus Medical, Inc. | -9.76% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
Correlation
The correlation between NVDA and GMED is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.06 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.26 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.27 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012 | 0.26 |
The correlation between NVDA and GMED shifts across timeframes, from 0.06 (1 year) to 0.27 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
NVDA:
$4.86T
GMED:
$10.63B
NVDA:
$6.53
GMED:
$4.28
NVDA:
30.73
GMED:
18.39
NVDA:
0.17
GMED:
0.19
NVDA:
19.35
GMED:
3.48
NVDA:
25.05
GMED:
2.30
NVDA:
$253.49B
GMED:
$3.10B
NVDA:
$187.95B
GMED:
$1.58B
NVDA:
$192.76B
GMED:
$803.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVDA vs. GMED — Risk / Return Rank
NVDA
GMED
NVDA vs. GMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NVIDIA Corporation (NVDA) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVDA | GMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.65 | ||
| Sortino ratioReturn per unit of downside risk | -1.48 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.26 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.65 | 2.26 | -1.61 |
| Martin ratioReturn relative to average drawdown | 1.32 | 4.92 | -3.60 |
Loading charts...
Drawdowns
NVDA vs. GMED - Drawdown Comparison
The maximum NVDA drawdown since its inception was -89.72%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for NVDA and GMED.
Loading charts...
Drawdown Indicators
| NVDA | GMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.72% | -47.91% | -41.81% |
Max Drawdown (1Y)Largest decline over 1 year | -20.21% | -22.10% | +1.89% |
Max Drawdown (3Y)Largest decline over 3 years | -36.88% | -44.40% | +7.52% |
Max Drawdown (5Y)Largest decline over 5 years | -66.34% | -47.91% | -18.43% |
Max Drawdown (10Y)Largest decline over 10 years | -66.34% | -47.91% | -18.43% |
Current DrawdownCurrent decline from peak | -14.74% | -18.62% | +3.88% |
Average DrawdownAverage peak-to-trough decline | -36.07% | -15.35% | -20.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.90% | 10.13% | -0.23% |
Volatility
NVDA vs. GMED - Volatility Comparison
NVIDIA Corporation (NVDA) and Globus Medical, Inc. (GMED) have volatilities of 12.04% and 12.47%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVDA | GMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.04% | 12.47% | -0.43% |
Volatility (6M)Calculated over the trailing 6-month period | 28.30% | 26.28% | +2.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.41% | 49.44% | -13.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.87% | 38.45% | +13.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.95% | 35.41% | +14.54% |
Dividends
NVDA vs. GMED - Dividend Comparison
NVDA's dividend yield for the trailing twelve months is around 0.14%, while GMED has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.14% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
Financials
NVDA vs. GMED - Financials Comparison
This section allows you to compare key financial metrics between NVIDIA Corporation and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVDA vs. GMED - Profitability Comparison
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
Frequently Asked Questions
NVDA and GMED have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMED has higher volatility (12.47%) compared to NVDA (12.04%). In terms of maximum drawdown, NVDA dropped -89.72% vs GMED's -47.91%.
GMED currently has the higher Sharpe Ratio (1.01 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVDA and GMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer